LumiraDx (LumiraDx) Current Accrued Expense : $32.99 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Current Accrued Expense?

LumiraDx's Current Accrued Expense for the quarter that ended in Jun. 2023 was $32.99 Mil.

LumiraDx's quarterly Current Accrued Expense declined from Dec. 2022 ($31.12 Mil) to Mar. 2023 ($0.00 Mil) but then increased from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($32.99 Mil).

LumiraDx's annual Current Accrued Expense increased from Dec. 2020 ($29.03 Mil) to Dec. 2021 ($32.61 Mil) but then declined from Dec. 2021 ($32.61 Mil) to Dec. 2022 ($31.12 Mil).

LumiraDx Current Accrued Expense Historical Data

The historical data trend for LumiraDx's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Current Accrued Expense Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Current Accrued Expense

29.03

32.61

31.12

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Current Accrued Expense	Get a 7-Day Free Trial								38.59	-	31.12	-	32.99

LumiraDx Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

LumiraDx Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of LumiraDx's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

LMDXF:USA

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.